2022
DOI: 10.1002/slct.202202271
|View full text |Cite
|
Sign up to set email alerts
|

Electrochemical Sensor for the Anti‐tuberculosis Drug Rifampicin on CuO@rGO‐Nanocomposite‐Modified GCE by Voltammetry Techniques

Abstract: Reduced-graphene-oxide layers (rGO) offer extremely subtle transducer thin-films and can be unified in interdigital microelectrodes for various purposes. Understanding the functions and nature of rGO specially bio-compatibility, we can use this as potent-tool for the detection of antibiotic-drug Rifampicin (RFP) in standard/pharmaceutical samples. Herein, we synthesize CuO@rGO nano-composite and explored its potency for the preparation of electrochemically-active-electrodes. Catalytic-activity of as-synthesize… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 59 publications
0
17
0
Order By: Relevance
“…RIF has an effectiveness of about 95% in cases of TB caused by susceptible strains [ 47 ], with a daily oral administration of the standard 600 mg single dose [ 24 , 48 ] or of a dose corresponding to 10–20 mg RIF/kg body weight [ 49 , 50 ]. Alone or in combination with other drugs, it represents the main treatment for infections (produced by various microorganisms), such as TB ( Mycobacteria tuberculosis ), osteomyelitis ( Staphylococcus aureus ), meningococcal disease ( Neisseria meningitidis ), leprosy ( Mycobacterium leprae ), gonorrhea ( Neisseria gonorrhoeae ) [ 51 ], Legionnaire’s disease ( Legionella pneumophila) [ 19 , 28 ] and even HIV [ 52 , 53 ]. Under regulated dosage, RIF is also recommended against methicillin-resistant Staphylococcus aureus [ 19 ], to treat cholestatic pruritus and infections associated with prosthetic joints [ 54 ], such as chemoprophylaxis of the postoperative endophthalmitis [ 55 ], or against Brucellosis and meningitis caused by Streptococcus pneumoniae , Haemophilus influenzae Type b and Neisseria meningitides [ 19 ].…”
Section: Rifamycins—properties and Clinical Treatmentmentioning
confidence: 99%
See 3 more Smart Citations
“…RIF has an effectiveness of about 95% in cases of TB caused by susceptible strains [ 47 ], with a daily oral administration of the standard 600 mg single dose [ 24 , 48 ] or of a dose corresponding to 10–20 mg RIF/kg body weight [ 49 , 50 ]. Alone or in combination with other drugs, it represents the main treatment for infections (produced by various microorganisms), such as TB ( Mycobacteria tuberculosis ), osteomyelitis ( Staphylococcus aureus ), meningococcal disease ( Neisseria meningitidis ), leprosy ( Mycobacterium leprae ), gonorrhea ( Neisseria gonorrhoeae ) [ 51 ], Legionnaire’s disease ( Legionella pneumophila) [ 19 , 28 ] and even HIV [ 52 , 53 ]. Under regulated dosage, RIF is also recommended against methicillin-resistant Staphylococcus aureus [ 19 ], to treat cholestatic pruritus and infections associated with prosthetic joints [ 54 ], such as chemoprophylaxis of the postoperative endophthalmitis [ 55 ], or against Brucellosis and meningitis caused by Streptococcus pneumoniae , Haemophilus influenzae Type b and Neisseria meningitides [ 19 ].…”
Section: Rifamycins—properties and Clinical Treatmentmentioning
confidence: 99%
“…Long-term or excess use of RIF may produce some adverse effects, the most important being hepatotoxicity, which causes liver damage leading, for example, to jaundice. Other side effects include fever [ 66 ], arthralgia [ 31 ], kidney failure [ 67 ], fatigue, dizziness, gastrointestinal disorders [ 68 ] generating nausea, vomiting, appetite loss, diarrhea, sore throat, headache, immunological [ 53 ] and allergic reactions [ 52 ]. Moreover, RIF causes orange coloration in urine, sweat and tears [ 28 ].…”
Section: Rifamycins—properties and Clinical Treatmentmentioning
confidence: 99%
See 2 more Smart Citations
“…These researchers modified GCE by rGO@CuO sensor and observed a three-fold increment in current values during electrochemical characterization of the sensor by CV and DPV. Sensors have shown very low DL 5–11 nM and remarkable stability (Sagar et al, 2022 ).…”
Section: Types Of Drugsmentioning
confidence: 99%